New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome

Clinical trial NCT06694363 · RECRUITING

Trial details

NCT number: NCT06694363
Sponsor: Assistance Publique - Hôpitaux de Paris
Status: RECRUITING
Study type: OBSERVATIONAL

Activated PI3K Delta Syndrome

Start date: 2025-06-26
Primary completion: 2029-06-27
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.